Dave Lashmet has been a biotech/medical analyst and sometimes a newsletter editor at Stansberry for a long time, and the latest iteration of his high-end newsletter is now called Stansberry Venture Technology (currently “on sale” for $2,500, no refunds)… and it’s now being promoted with a “cure for cancer” spiel, so we obviously all want […]
Articles
I’ve got a few stocks to mention in the medical space this week — one to update that’s in my portfolio, one to confirm as a teaser pick (since folks keep asking) after several Gumshoe readers discussed it last week, and one to note as a teaser idea that’s being pushed pretty heavily (though the […]
We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.
More Info
Comments
I have paid for Alpha 9 and the Money Weekly Call. After the great membership service support, the customer service is ...
Varian Medical Systems (NYSE:VAR), which uses klystrons in radiation therapy devices, had $3 billion in sales last year....
Varian Medical Systems, Inc. (VAR) seems like significant news for treatment of tumors, posted in my support group yeste...
Robert - here is my take on those three companies. But, I would prefer if one of our esteemed docs offered a more profe...
Regarding Oxford's Teaser for Varian Medical. Travis, this one sure looked familiar. Remembered why - almost the sam...
Actually....I don't think this tease is intended to be Accuray... I believe it's intended company is: Varia...
I think Varian Medical is way out in front of these people. They have a radiation projection device "IMRT"which not...